Philip Schauer, M.D.

Philip R. Schauer, MD, is Chief of Minimally Invasive General Surgery and Director of the Cleveland Clinic Bariatric and Metabolic Institute. He is also Professor of Surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He is immediate Past President of the American Society for Metabolic and Bariatric Surgery.

After receiving his medical degree from the Baylor College of Medicine in Houston, Dr. Schauer completed his residency in surgery at the University of Texas, where he served as Chief Resident of
General Surgery. He then completed a fellowship in laparoscopic surgery at Duke University Medical Center in Durham, N.C. Prior to joining Cleveland Clinic in 2004, Dr. Schauer served as Director of Endoscopic Surgery, Director of Bariatric Surgery and Director of the Mark Ravitch/Leon Hirsch Center for Minimally Invasive Surgery at the University of Pittsburgh Medical Center.
 
Dr. Schauer's clinical interests include surgery for severe obesity, minimally invasive surgery(laparoscopic) and gastrointestinal surgery. He has performed more than 4,000 operations for severe obesity. His research interests include the pathophysiology of obesity and related diseases, physiologic effects of laparoscopic surgery on postoperative injury and recovery, and outcomes of laparoscopic management of obesity, gastrointestinal diseases and hernias. He has also participated in the development of new minimally invasive, endoscopic and laparoscopic operations.

New concepts in surgical training and education have been a major focus of his educational interests. He has authored more than 200 scientific papers, editorials, textbook chapters, abstracts and video productions. He has been an invited speaker for more than 100 regional, national and international lectures on the subject of obesity surgery and laparoscopic surgery. He has been on the board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) for the last 5 years. He is Past Chairman of the research, as well as training and credentialing committees of the American Society for Bariatric Surgery. He is also a member of International Federation of Surgery for Obesity (IFSO), the North American Society for the Study of Obesity (NAASO), the American Surgical Association, the Society of University Surgeons, the Society of Surgery of the Alimentary Tract (SSAT), Central Surgical Society and the Society of Clinical Surgery. He is a member of the American Board of Surgery Advisory Council and a member of the Board of Governors of the Fellowship Council. He is the Associate Editor of the new journal, Surgery for Obesity and Related Diseases and is on the editorial board of three other surgical journals. He has been director of more than 50 courses and workshops on advanced laparoscopic surgery and has trained more than 20 fellows in advanced laparoscopic surgery.

Past President, American Society for Metabolic and Bariatric Surgeons

Laparoscopic surgery, bariatric surgery, gastrointestinal surgery, colon surgery, weight loss surgery, weight management.

• Innovator in development of numerous minimally invasive gastrointestinal procedures 
• Innovator in bariatric surgical techniques and devices for weight loss and diabetes control

• Best  Doctors in America, 5 consecutive years
• Principal Investigator: STAMPEDE  Randomized Controlled Trial, Medical vs. Surgical Management of Type II Diabetes

• American Surgical Association
• American Society for Metabolic and Bariatric Surgery
• Fellow, American College of Surgeons
• Society of American Gastrointestinal and Endoscopic Surgeons
• Obesity Society

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 10/17/2008, Dr. Schauer has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting.  Dr. Schauer receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:

• Bard-Davol
• Baxter Healthcare Corporation
• Cardinal Health
• Ethicon Endo-Surgery, Inc.
• Stryker
• W. L. Gore & Associates Inc.

Equity.  Dr. Schauer owns stock or stock options in the following companies for activities as a founder, inventor, or consultant:

• Barosense
• Surgical Excellence
• Surgiquest

Fiduciary Role.  Dr. Schauer serves in a fiduciary capacity, such as an officer or director, for the following companies or other entities:

• MISS Surgery Symposium
• Physician Reviews of Surgery (PRS), LLC
• RemedyMD, Inc.
• Surgical Excellence

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)